Agenus Inc (AGEN)
15.69
+0.58
(+3.84%)
USD |
NASDAQ |
May 31, 16:00
15.66
-0.03
(-0.19%)
After-Hours: 20:00
Agenus Max Drawdown (5Y): 96.18% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 96.18% |
April 30, 2024 | 96.18% |
March 31, 2024 | 91.85% |
February 29, 2024 | 91.34% |
January 31, 2024 | 91.34% |
December 31, 2023 | 90.34% |
November 30, 2023 | 90.34% |
October 31, 2023 | 88.40% |
September 30, 2023 | 82.78% |
August 31, 2023 | 80.78% |
July 31, 2023 | 83.74% |
June 30, 2023 | 83.74% |
May 31, 2023 | 83.74% |
April 30, 2023 | 83.74% |
March 31, 2023 | 83.74% |
February 28, 2023 | 83.74% |
January 31, 2023 | 83.74% |
December 31, 2022 | 83.74% |
November 30, 2022 | 83.74% |
October 31, 2022 | 83.74% |
September 30, 2022 | 83.74% |
August 31, 2022 | 83.74% |
July 31, 2022 | 83.74% |
June 30, 2022 | 83.74% |
May 31, 2022 | 83.74% |
Date | Value |
---|---|
April 30, 2022 | 83.74% |
March 31, 2022 | 83.74% |
February 28, 2022 | 83.74% |
January 31, 2022 | 83.74% |
December 31, 2021 | 83.74% |
November 30, 2021 | 83.74% |
October 31, 2021 | 83.74% |
September 30, 2021 | 83.74% |
August 31, 2021 | 83.74% |
July 31, 2021 | 83.74% |
June 30, 2021 | 83.74% |
May 31, 2021 | 83.74% |
April 30, 2021 | 83.74% |
March 31, 2021 | 83.74% |
February 28, 2021 | 83.74% |
January 31, 2021 | 83.74% |
December 31, 2020 | 83.74% |
November 30, 2020 | 83.74% |
October 31, 2020 | 83.74% |
September 30, 2020 | 83.74% |
August 31, 2020 | 83.74% |
July 31, 2020 | 83.74% |
June 30, 2020 | 83.74% |
May 31, 2020 | 83.74% |
April 30, 2020 | 83.74% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
80.78%
Minimum
Aug 2023
96.18%
Maximum
Apr 2024
84.78%
Average
83.74%
Median
Jun 2019
Max Drawdown (5Y) Benchmarks
Ligand Pharmaceuticals Inc | 77.41% |
Protalix BioTherapeutics Inc | 94.35% |
InfuSystems Holdings Inc | 72.34% |
PAVmed Inc | 98.98% |
Allogene Therapeutics Inc | 95.78% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -41.32 |
Beta (5Y) | 1.352 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 85.53% |
Historical Sharpe Ratio (5Y) | -0.2665 |
Historical Sortino (5Y) | -0.6252 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.26% |